The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index; 27 of the 178 sources its claims cite were checked for support.
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Open accessAbstract
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients’ state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depression. The latest research into inflammatory cytokines shows that their relationship with the etiology of depression is causative. There are stronger cytokine reactions to pathogens and stressors in depression. If combined with other predisposing factors, responses lead to prolonged inflammatory processes, prolonged dysregulation of various axes, stress, pain, mood changes, anxiety, and depression. This review focuses on the most recent data on cytokines as markers of depression concerning their roles in its pathogenesis, their possible use in diagnosis and management, their different levels in bodily fluids, and their similarities in animal studies. However, cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders. Their effects are only a part of the whole pathway.
Overview
CoChat Summary
TL;DR
This narrative review summarizes evidence that inflammatory cytokines such as IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF are altered in depression and may serve as biomarkers for diagnosis, severity, and treatment response. It concludes that cytokines are viable research targets, but findings are inconsistent and causality remains unclear.
Key findings
- Cytokines including IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF-α are repeatedly associated with depression; the review concludes they are viable options for quantitative depression research, preferably using non-invasively collected bodily fluids.
- Meta-analytic evidence cited includes elevated IL-3 in depression (107 studies, 5,166 patients and 5,083 controls), elevated IL-12 in an 82-study meta-analysis, and a mean sIL-2R difference of 0.555 U/mL between healthy subjects and MDD patients.
- Some markers relate to treatment: elevated baseline TNF was associated with worse antidepressant outcomes; IL-17A was elevated in MDD non-responders; IL-13 showed a 69% reduction at week 52 of SSRI treatment; multi-assay panels including sTNFR2 achieved 69.2% correct classification (62.5% sensitivity, 82.5% specificity) and, in another panel, 91.1% sensitivity and 81.3% specificity for MDD.
- Findings are often contradictory: IL-1β, IL-6, IL-8, IL-10, CCL2, CCL5, and TNF show conflicting elevations or decreases across studies, with unclear relationships between peripheral and CSF levels and between animal and human results.
Methods
- Narrative review of recent data on cytokines as markers of depression, covering their roles in pathogenesis, diagnosis, management, bodily fluid levels, and similarities in animal studies.
- The paper synthesizes human clinical studies, meta-analyses, systematic reviews, and animal models, organized cytokine by cytokine.
- No systematic search strategy, inclusion criteria, or quality assessment is stated in the paper.
Limitations
- The paper states that cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders and that their effects are only part of the whole pathway.
- The paper repeatedly notes inconsistent findings, unclear cause-versus-consequence relationships, and differences between peripheral and central levels or between animal models and human patients.
- Evident from the text: as a narrative review without a described systematic search or quality appraisal, it may be subject to selection and interpretation bias, and many cited studies are small or heterogeneous.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
22 Valid · 0 Not valid · 113 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis concluded that IL-1β was significantly elevated in patients with depression and Alzheimer’s disease (AD), while IL-6 was elevated only in patients with depression [38].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Partly supportedcites [38] Ng, 2018, IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s Disease: Systematic Review and Meta-Analysis, Sci. Rep. sourceExperimental — accuracy not yet measured
The Results (Meta-Analysis for Elderly with and without Alzheimer’s disease) report significantly higher peripheral IL-1β in elderly patients with Alzheimer’s disease than in controls (p = 0.041). The Discussion qualifies this as significant before Bonferroni adjustment, and the Conclusion says that after correction for multiple testing, only IL-6 in elderly patients with depression remained significantly elevated. The citing sentence omits that qualification. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“P2X7 inhibition has been associated with antidepressant-like effects, and IL-1β knockout mice failed to express these receptors [48,49].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Not checked yetcites [48] Seil, 2012, Distinct Regulation by Lipopolysaccharides of the Expression of Interleukin-1β by Murine Macrophages and Salivary Glands, Innate Immun. source
- Could not verifycites [49] Clark, 2010, P2X7-Dependent Release of Interleukin-1 and Nociception in the Spinal Cord Following Lipopolysaccharide, J. Neurosci. sourceExperimental — accuracy not yet measured
The Results section on LPS-induced mechanical hypersensitivity reports that P2X7 antagonists prevented hyperalgesia, not that they had antidepressant-like effects. A search for depression and antidepressant-like behavior found no passage addressing that outcome in our copy; page numbers were unavailable. (LLM, conf=0.75)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elomaa et al. described elevated IL-5 levels in 58 patients with MDD, though a later meta-analysis did find changes in levels of IL-5 to be inconclusive in depressed patients.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.5. Interleukin-5
What the sources say
- Supportedcites [35] Freitas, 2017, Peripheral Cytokine and Chemokine Alterations in Depression: A Meta-Analysis of 82 Studies, Acta Psychiatr. Scand. source
The 'Other mediators' section of our copy lists IL-5 among mediators measured in at least three studies and states that levels 'did not significantly differ between individuals with MDD and HCs'. Table 1 gives the IL-5 primary meta-analysis as 4 studies (198 MDD vs 322 controls), Hedge's g = 0.396 (95% CI -0.072 to 0.865), P = 0.097, I² = 82.1% — a non-significant, borderline estimate with large heterogeneity, i.e. no established IL-5 change in depression. The citing paraphrase renders the paper's null/borderline result as 'inconclusive', which is a fair (if slightly hedged) restatement of what this 2017 meta-analysis reports for IL-5 in MDD patients. (LLM, conf=0.86)
- Not checked yetcites [77] Ho, 2021, Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer, J. Psychiatr. Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Female rats with lower IL-8 levels are more susceptible to medication and electroconvulsive therapy (ECT) [92,93].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.7. Interleukin-8
What the sources say
- Partly supportedcites [92] Kruse, 2021, Depression Treatment Response to Ketamine: Sex-Specific Role of Interleukin-8, but Not Other Inflammatory Markers, Transl. Psychiatry sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that lower baseline IL-8 was associated with better ECT response in female patients. The Discussion also reports an association with antidepressant-medication response, but says sex differences were not evaluated in those studies. These findings concern people, not female rats. (LLM, conf=0.90)
- Partly supportedcites [93] Kruse, 2020, Inflammation and Depression Treatment Response to Electroconvulsive Therapy: Sex-Specific Role of Interleukin-8, Brain Behav. Immun. sourceExperimental — accuracy not yet measured
The Discussion reports that lower baseline IL-8 was associated with improvement after ECT in female patients, not female rats. It also reports lower baseline IL-8 among antidepressant-medication responders in a meta-analysis, but says that analysis did not evaluate sex. Thus neither the rat population nor a female-specific medication response is supported. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“IL-4-driven Arg1+ microglia in the hippocampus trigger brain-derived neurotrophic factor (BDNF)-driven neurogenesis in reaction to stress, resulting in improved resilience to stress-induced depression.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.4. Interleukin-4
What the sources say
- Supportedcites [69] Zhang, 2021, IL4-Driven Microglia Modulate Stress Resilience through BDNF-Dependent Neurogenesis, Sci. Adv. source
The Discussion states that IL4-driven Arg1+ microglia ameliorate chronic stress–induced depressive-like behaviors in mice through BDNF-dependent hippocampal neurogenesis. The Results section on stress-induced depressive-like behaviors also reports that blocking BDNF signaling or neurogenesis abolished the protective effect. (LLM, conf=0.93)
- Not checked yetcites [70] Wachholz, 2017, Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior, Behav. Brain Res. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
105 more claims · 13 with their cited sources checked
Create a free account to see all 158 claims and to verify the 151 references still open.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 11
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar associations have been reported with cytokines and neuropeptides in depression (13).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.11. Interleukin-13
“The above-cited meta-analysis by Köhler et al. underpins the association between peripheral IL-13 elevation and MDD [14].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“14. Siwek M. Sowa-Kućma M. Dudek D. Styczeń K. Szewczyk B. Kotarska K. Misztak P. Pilc A. Wolak M. Nowak G. Oxidative Stress Markers in Affective Disorders”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
“The use of intrahippocampal IL-1RA causes downregulation of brain-derived neurotrophic factor (BDNF) in individuals experiencing social isolation [52].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“Brain-Derived Neurotrophic Factor MRNA Downregulation Produced by Social Isolation Is Blocked by Intrahippocampal Interleukin-1 Receptor Antagonist”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“namely c.-1211T > C—TNF-α (rs1799964)”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“the C allele in the C/T genotype of rs179964 was associated with positive treatment outcomes and low serum levels of TNF.”
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475 · cited 1×
“Cytokines, hormones, oxidative stress markers, and neuropeptides have been studied in association with depression [8].”
BackgroundSantomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444 · cited 1×
“6%, and while the prevalence is rising globally, the late SARS-CoV-2 pandemic caused problems, especially in middle- and low-income countries [3,4].”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Levels of cytokines have been found significantly altered in depression, and patients, even if otherwise clinically healthy, show elevated or decreased levels of various cytokines and their soluble receptors in bodily fluids [18].”
BackgroundThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223 · cited 1×
“This cytokine was first implicated in the etiology of sickness behavior and later linked to depressive disorder along with IL-6 and TNF [36,37].”
BackgroundPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
Research works printed but not linked: 9
- (2022, December 18). IL3 Interleukin 3 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3562.
- (2022, November 30). IL12A Interleukin 12A [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3592.
- (2022, November 30). IL12B Interleukin 12B [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3593.
- (2022, November 30). IL13 Interleukin 13 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3596.
- (2022, December 13). IL17A Interleukin 17A [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3605.
- (2022, November 30). IL18 Interleukin 18 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3606.
- (2022, December 13). CCL2 C-C Motif Chemokine Ligand 2 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/6347.
- (2022, November 30). TNF Tumor Necrosis Factor [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/7124.
- (2022, November 30). TNFRSF1B TNF Receptor Superfamily Member 1B [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/7133.
Cited by
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 177
Cardiovascular disease and depression: a narrative review
Li, X., Zhou, J., Wang, M., Yang, C., & Sun, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1274595 · Cited by 129
Pathogenesis and treatment of depression: Role of diet in prevention and therapy
Mrozek, W., Socha, J., Sidorowicz, K., Skrok, A., Syrytczyk, A., Piątkowska‐Chmiel, I., & Herbet, M. (2023) · Nutrition · doi:10.1016/j.nut.2023.112143 · Cited by 78
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Wu, C., Mu, Q., Gao, W., & Lu, S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03310-w · Cited by 85
Inflammatory biomarkers in depression: scoping review
Paganin, W., & Signorini, S. (2024) · BJPsych Open · doi:10.1192/bjo.2024.787 · Cited by 57
Metadata
- Authors
- Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M.
- Affiliations
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia
- Comenius University Bratislava (SK)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-29
- Volume
- 24
- Issue
- 1
- Pages
- 578
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820159
- OpenAlex
- W4313361124
- Semantic Scholar
- ff8ea139489ad0c55b6a066d65875eb9feda6c69
- Cited by
- 299
- References
- 218
- Citations by year
- 2026: 71 · 2025: 117 · 2024: 82 · 2023: 29
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, biomarkers, cytokines, inflammation, major depressive disorder, oxidative stress, neuropeptides, stress response, animal models of depression, depression diagnosis, depression pathogenesis
- MeSH terms
- Animals, Depression, Depressive Disorder, Major, Major Depressive Disorder, Inflammation, Quality of Life, Biomarkers, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selected biomarkers of depression: what are the effects of cytokines and inflammation. https://app.cochat.ai/papers/10.3390/ijms24010578
- The paper
- Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022). Selected biomarkers of depression: what are the effects of cytokines and inflammation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
